Coffee Consumption Lowers Prostate Cancer Threat
Since ages coffee has been infamous for its caffeine content and adverse effects. Recent researches have revealed an important aspect of coffee consumption. Drink enough water to compensate the dehydration caused by coffee. Avoid other forms of caffeine such as energy drinks and soda that do not yield health benefits.
Studies conducted at the Harvard Public School in Boston have revealed that daily consumption of six or more cups of coffee helps you reduce the risk of developing prostate cancer by 60 percent.
AdvertisementThe health benefits were identical with both caffeinated and decaffeinated coffee because the benefits were related with antioxidants and not the caffeine present in the coffee.
It is seen that men who regularly drink coffee lower their risk of prostate cancer.
Kashif Shafique et al conducted a prospective cohort study that was published in Nutrition Journal 2012, to evaluate the connection between risk of Gleason grade-specific prostate cancer and coffee consumption.
A total of 6017 men were enrolled in this cohort study in England between 1970 and 1973 and were followed up to 31st December 2007.
The study revealed that coffee consumption was inversely proportional to the risk of prostate cancer. It was observed that men who drank three or more cups of coffee a day had 55 percent less chances of high Gleason grade disease.
Factors such as cholesterol level, systolic blood pressure, smoking, body mass index, alcohol consumption and tea intake slightly changed the statistics.
It was concluded that heavy coffee drinkers are less prone to the threat of prostate cancer as compared to non-coffee drinkers. Drinking coffee lowers the risk of prostate cancer but it does not rule out the complete threat of the prostate cancer.
Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Kashif Shafique et al; Nutrition Journal 2012
PDecline of Binge Eating from Adolescence to Adulthood Relationship Between Metabolic Syndrome and Inflammatory Biomarkers M